Accrual Quality Improvement Program for clinical trials
Clinical Trials · 2024
DOI: 10.1177/17407745241243027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Trials, 2024. Verfasst von Ellen Richmond und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA. Hauptthemen laut MEDLINE: Quality Improvement, Clinical Trials as Topic, Patient Selection. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.
Abstract (Originalsprache)
Background
The Early Phase Cancer Prevention Clinical Trials Program (Consortia), led by the Division of Cancer Prevention, National Cancer Institute, supports and conducts trials assessing safety, tolerability, and cancer preventive potential of a variety of interventions. Accrual to cancer prevention trials includes the recruitment of unaffected populations, posing unique challenges related to minimizing participant burden and risk, given the less evident or measurable benefits to individual participants. The Accrual Quality Improvement Program was developed to address these challenges and better understand the multiple determinants of accrual activity throughout the life of the trial. Through continuous monitoring of accrual data, Accrual Quality Improvement Program identifies positive and negative factors in real-time to optimize enrollment rates for ongoing and future trials.
Methods
The Accrual Quality Improvement Program provides a web-based centralized infrastructure for collecting, analyzing, visualizing, and storing qualitative and quantitative participant-, site-, and study-level data. The Accrual Quality Improvement Program approaches cancer prevention clinical trial accrual as multi-factorial, recognizing protocol design, potential participants’ characteristics, and individual site as well as study-wide implementation issues.
Results
The Accrual Quality Improvement Program was used across 39 Consortia trials from 2014 to 2022 to collect comprehensive trial information. The Accrual Quality Improvement Program captures data at the participant level, including number of charts reviewed, potential participants contacted and reasons why participants were not eligible for contact or did not consent to the trial or start intervention. The Accrual Quality Improvement Program also captures site-level (e.g. staffing issues) and study-level (e.g. when protocol amendments are made) data at each step of the recruitment/enrollment process, from potential participant identification to contact, consent, intervention, and study completion using a Recruitment Journal. Accrual Quality Improvement Program’s functionality also includes tracking and visualization of a trial’s cumulative accrual rate compared to the projected accrual rate, including a zone-based performance rating with corresponding quality improvement intervention recommendations.
Conclusion
The challenges associated with recruitment and timely completion of early phase cancer prevention clinical trials necessitate a data collection program capable of continuous collection and quality improvement. The Accrual Quality Improvement Program collects cumulative data across National Cancer Institute, Division of Cancer Prevention early phase clinical trials, providing the opportunity for real-time review of participant-, site-, and study-level data and thereby enables responsive recruitment strategy and protocol modifications for improved recruitment rates to ongoing trials. Of note, Accrual Quality Improvement Program data collected from ongoing trials will inform future trials to optimize protocol design and maximize accrual efficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA.
ORCID-Profile: Goli Samimi, Leslie G Ford, Eva Szabo
Förderung
- Intramural NIH HHS
Zitieren
APA
Richmond, E., Samimi, G., House, M., Ford, L. G., & Szabo, E. (2024). Accrual Quality Improvement Program for clinical trials. Clinical Trials. https://doi.org/10.1177/17407745241243027
Vancouver
Richmond E, Samimi G, House M, Ford LG, Szabo E. Accrual Quality Improvement Program for clinical trials. Clinical Trials. 2024. doi:10.1177/17407745241243027
BibTeX
@article{Richmond2024,
author = {Richmond, Ellen and Samimi, Goli and House, Margaret and Ford, Leslie G and Szabo, Eva},
title = {Accrual Quality Improvement Program for clinical trials},
journal = {Clinical Trials},
year = {2024},
doi = {10.1177/17407745241243027}
}
EUVIMED